Nanjing Dashan Zimei Pharmaceuticals Technology Co., Ltd.
Nanjing Dashan Zimei Pharmaceuticals Technology Co., Ltd., commonly referred to as Dashan Zimei, is a prominent player in the pharmaceutical industry, headquartered in Nanjing, China. Established in 2005, the company has rapidly expanded its operational reach across various regions, focusing on the development and manufacturing of innovative pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, Dashan Zimei is recognised for its commitment to quality and compliance with international standards. The company’s unique approach to research and development has led to several key milestones, including the successful launch of multiple proprietary formulations. With a strong market position, Dashan Zimei has garnered a reputation for excellence, contributing significantly to the global pharmaceutical landscape. Its dedication to advancing healthcare solutions underscores its role as a trusted partner in the industry.
DitchCarbon Score
How does Nanjing Dashan Zimei Pharmaceuticals Technology Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nanjing Dashan Zimei Pharmaceuticals Technology Co., Ltd.'s score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nanjing Dashan Zimei Pharmaceuticals Technology Co., Ltd.'s reported carbon emissions
Nanjing Dashan Zimei Pharmaceuticals Technology Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for the most recent year, nor do they have documented reduction targets or climate pledges. This absence of specific emissions figures indicates a potential area for improvement in transparency regarding their environmental impact. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing carbon emissions and committing to sustainability initiatives. While Nanjing Dashan Zimei Pharmaceuticals has not yet established measurable targets or commitments, the industry trend suggests a growing emphasis on reducing Scope 1, 2, and 3 emissions. As the company moves forward, developing clear climate commitments and reduction strategies will be essential for aligning with global sustainability goals and enhancing their corporate responsibility profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nanjing Dashan Zimei Pharmaceuticals Technology Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
